Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Canaccord Genuity Maintains Buy on Nuvei, Lowers Price Target to $34

Author: Benzinga Newsdesk | April 02, 2024 08:17am
Canaccord Genuity analyst Joseph Vafi maintains Nuvei (NASDAQ:NVEI) with a Buy and lowers the price target from $40 to $34.

Posted In: NVEI TSX:NVEI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist